Showing results (1851-1860 of 2,093) with videos related to

Sort By:
Pageof 210
Archives of Otolaryngology--Head & Neck Surgery|October 17, 2007
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709Amit Agrawal, James Moon, R Kim Davis, et al.
American Journal of Ophthalmology|February 7, 2006
Polymerase chain reaction and Goldmann-Witmer coefficient analysis are complimentary for the diagnosis of infectious uveitisJolanda D F De Groot-Mijnes, Aniki Rothova, Anton M Van Loon, et al.
Genitourinary Medicine|August 1, 1986
Topical treatment of recurrent genital herpes simplex virus infections with trisodium phosphonoformate (foscarnet): double blind, placebo controlled, multicentre studyS E Barton, P E Munday, G R Kinghorn, et al.
Journal of Surgical Education|November 30, 2020
Trainee Autonomy in Minimally Invasive General Surgery in the United States: Establishing a National BenchmarkJordan D Bohnen, Brian C George, Joseph B Zwischenberger, et al.
Nature|May 3, 2019
Subthreshold firing in Mott nanodevicesJavier Del Valle, Pavel Salev, Federico Tesler, et al.
Journal of the American Chemical Society|February 22, 2023
Molecular Basis of the Electron Bifurcation Mechanism in the [FeFe]-Hydrogenase Complex HydABCAlexander Katsyv, Anuj Kumar, Patricia Saura, et al.
The Review of Scientific Instruments|November 11, 2025
The x-ray color camera microscope-A combined x-ray diffraction and fluorescence analysis instrument suitable for lab and synchrotron useArno Frank, Philip Cook, Dieter Ingerle, et al.
Physical Review Letters|December 21, 2011
Upper limit to magnetism in LaAlO3/SrTiO3 heterostructuresM R Fitzsimmons, N W Hengartner, S Singh, et al.
Biomicrofluidics|July 10, 2018
Engineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signalingBarbara Bachmann, Sarah Spitz, Mario Rothbauer, et al.
The Journal of Infectious Diseases|July 1, 2008
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccineE Tauber, H Kollaritsch, F von Sonnenburg, et al.
Pageof 210